Početna › Ewingov sarkom › Florida
Kliničke studije za Ewingov sarkom u državi Florida
7 studija za Ewingov sarkom traži sudionike na lokacijama u državi Florida.
Gradovi u državi Florida
Službeni tekst studije (engleski)
Metastatic Ewing's Trial Testing Schedule Enhancement to Improve Outcomes
- University of Florida, Gainesville
- Nemours Jacksonville, Jacksonville
- University of Miami, Miami
- i još 2
U tijeku regrutacijaFaza 1
Od 1 godina i više · Oba spola · Ažurirano 25. ruj 2026. · NCT07194044Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
- Johns Hopkins All Children's Hospital ( Site 1025), St. Petersburg
U tijeku regrutacijaFaza 1/2
6 Months – 25 Years · Oba spola · Ažurirano 17. ruj 2026. · NCT06395103Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
- University of Florida, Gainesville
- Nicklaus Children's Hospital, Miami
- Arnold Palmer Hospital for Children, Orlando
- i još 1
U tijeku regrutacijaFaza 1/2
Do 26 godina · Oba spola · Ažurirano 3. ruj 2026. · NCT06465199Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
- University of Florida, Gainesville
- Nicklaus Children's Hospital, Miami
- Arnold Palmer Hospital for Children, Orlando
- i još 2
U tijeku regrutacijaFaza 1/2
Do 30 godina · Oba spola · Ažurirano 3. ruj 2026. · NCT06541262Eflornithine (DFMO) for Ewing Sarcoma and Osteosarcoma
- St. Joseph's Children's Hospital, Tampa
U tijeku regrutacijaFaza 2
Od 0 do 50 godina · Oba spola · Ažurirano 9. srp 2026. · NCT07321912Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors
- University of Florida, Gainesville
U tijeku regrutacijaFaza 1/2
6 Months – 25 Years · Oba spola · Ažurirano 30. lip 2026. · NCT06625190Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma
- Johns Hopkins All Children's Hospital, St. Petersburg
U tijeku regrutacijaFaza 1/2
Od 2 do 30 godina · Oba spola · Ažurirano 3. velj 2026. · NCT05734066Iz ClinicalTrials.gov, podaci preuzeti 4. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.